LIVN
LivaNova PLC
NASDAQ: LIVN · HEALTHCARE · MEDICAL DEVICES
$58.92
-3.87% today
Updated 2026-04-29
Market cap
$3.51B
P/E ratio
—
P/S ratio
2.53x
EPS (TTM)
$-4.45
Dividend yield
—
52W range
$35 – $72
Volume
0.9M
LivaNova PLC (LIVN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$58.92
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$102.04
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -17.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.